about
Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorderHypernasality associated with basal ganglia dysfunction: evidence from Parkinson's disease and Huntington's diseasePhonatory dysfunction as a preclinical symptom of Huntington disease.Objective acoustic quantification of phonatory dysfunction in Huntington's diseaseEye movements in ephedrone-induced parkinsonismSpatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).Diffusion tensor imaging in the characterization of multiple system atrophy.Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder.High-accuracy voice-based classification between patients with Parkinson's disease and other neurological diseases may be an easy task with inappropriate experimental design.Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.Fast vergence eye movements are disrupted in Parkinson's disease: A video-oculography study.Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.Acoustic investigation of stress patterns in Parkinson's disease.Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.Characteristics of motor speech phenotypes in multiple sclerosis.Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.Tests of manual dexterity and speed in Parkinson's disease: Not all measure the same.Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.Automatic detection of Parkinson's disease in running speech spoken in three different languages.Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study.Speech changes after coordinative training in patients with cerebellar ataxia: a pilot study.Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.The Atlas of Physiology and Pathophysiology: Web-based multimedia enabled interactive simulationsQuantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's diseaseAcoustic assessment of voice and speech disorders in Parkinson's disease through quick vocal testCharacterization Methods for the Detection of Multiple Voice Disorders: Neurological, Functional, and Laryngeal DiseasesEffect of pallidal deep-brain stimulation on articulation rate in dystoniaDistinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophyEye movement abnormalities are associated with brainstem atrophy in Wilson disease
P50
Q30356478-5C5E281B-52D5-4C21-9487-51F107E8A80DQ30372951-38EE388E-4A56-4D6A-852B-A0AE84B771DAQ30425545-292E8751-DD5C-4E41-B983-3BAEF5853349Q30453596-4FC0F4E3-323C-4D3B-AB21-99012732600BQ34035394-AFDC882F-F8F9-4CEC-8B2E-14A8D88E0227Q35102755-7ABE8E40-3B17-4847-BCAE-10F734CC6E48Q37226500-652E2853-AEBA-4220-AF4F-21D3D47B9732Q38954289-7C084BDC-A070-46A3-8A31-064597549A01Q39004650-D9C9AFB3-9B5A-4856-8FC8-0BFA43AF7776Q39117135-0CF80580-EB78-4CAB-A677-AF753AA92D81Q41433471-7CE93AF3-91C9-4150-BAAB-B5D4D2F3AE1EQ45160258-91826C9A-6120-46F7-9D43-FDEF52B35455Q45299193-ED30EAB4-B89F-41D4-A4B8-A397659FD439Q45961215-200409B4-BA89-4911-AC6B-EDCC979D9B1EQ46137935-066144CF-2ADC-4C06-AFA9-8A0D88465920Q47337091-AC973735-ADD7-4FD1-B2C7-036093AAEAC4Q48414504-DD0A4104-F1B7-45ED-8685-0A0F67359263Q48732667-3AAD5CDD-AB31-4711-A3B9-382FF0A4468CQ50243326-A3C19E15-1A0A-409A-A1EC-FF7FC249C407Q50537024-FCA55A21-2568-48DB-A401-4045A2F99D1DQ50607834-5A9A3BB3-B844-4510-B656-34CA4E65CE3DQ50927521-8C8E5712-E9FF-4DDE-92E9-149692708A77Q51717809-1F148EF5-D6D2-4B7A-AF78-5BE1B6FD99D0Q55339951-2D468EC5-F6C5-4483-828E-7F236E945930Q83200802-4675E925-C577-4E71-BB3F-D614733146E7Q83388694-416C4A12-0756-43F6-847A-53FE43602CB1Q83836549-895C90FA-C930-4C5E-8701-DA66B226E32AQ85907677-EC3679AB-3609-49F1-A99B-4F58877D27C6Q90954143-4E6A858E-30E3-45EB-8F63-77ECE4DF9FE7Q92288203-3D8B6887-1224-4077-9048-F074E386AAC0Q92387884-573379D1-7A32-4A16-A8C6-9FB7C7CA5B43
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1036-3054
@en
name
Jan Rusz
@ast
Jan Rusz
@en
Jan Rusz
@es
Jan Rusz
@nl
type
label
Jan Rusz
@ast
Jan Rusz
@en
Jan Rusz
@es
Jan Rusz
@nl
prefLabel
Jan Rusz
@ast
Jan Rusz
@en
Jan Rusz
@es
Jan Rusz
@nl
P106
P2456
P31
P496
0000-0002-1036-3054